National Centre for Pharmacoeconomics

National Centre for
Pharmacoeconomics

NCPE Ireland

Levonorgestrel Intrauterine System (Levosert®) for contraception and for the treatment of heavy menstrual bleeding.

 

NCPE Assessment Process Complete
Rapid review commissioned 28/08/2019
Rapid review completed 23/10/2019
Rapid Review outcome A full HTA is not recommended. The NCPE recommends that levonorgestrel-IUS (Levosert®) be considered for reimbursement.